FutureChem Co., Ltd. Logo

FutureChem Co., Ltd.

Develops radiopharmaceuticals & diagnostic agents for cancer, Alzheimer's, and Parkinson's disease.

220100 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 성동구 성수일로8길 59 평화빌딩 B동 3층(성수동2가), 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

FutureChem Co., Ltd. is a global radiopharmaceutical company specializing in the development, manufacturing, and distribution of radioactive medical products. The company's portfolio focuses on diagnostic agents for conditions such as various cancers, Alzheimer's, and Parkinson's disease. In addition to finished pharmaceuticals, FutureChem produces and supplies related precursors, chemical compounds, synthesis reagents, and automated synthesis modules. The company actively establishes international partnerships to expand its presence in the global nuclear medicine and molecular imaging markets.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.9 KB
2025-09-15 00:00
Legal Proceedings Report
[기재정정]투자판단관련주요경영사항(임상시험결과) (전립선암 치료용 [Lu177]Ludotadipep 방사성의약품 FC7…
Korean 25.0 KB
2025-09-04 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험계획승인신청등결정) (전이성 거세저항성 전립선암 환자에서 [177Lu]루도타다이 펩의 유…
Korean 12.4 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.7 MB
2025-07-14 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.7 KB
2025-07-10 00:00
Regulatory News Service
투자판단관련주요경영사항 (프로스타뷰([F18]플로라스타민)주사액 식품의약품안전처 신약 허가)
Korean 13.7 KB
2025-07-09 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험결과) ([F18]Florastamin 제3상 임상시험 결과보고서 수령)
Korean 12.1 KB
2025-07-09 00:00
Regulatory News Service
투자판단관련주요경영사항(임상시험결과) ([F18]Florastamin 제3상 임상시험 결과보고서 수령)
Korean 12.7 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.6 MB
2025-04-08 00:00
Legal Proceedings Report
투자판단관련주요경영사항(임상시험결과) (전립선암 치료용 [Lu177]Ludotadipep 방사성의약품 FC705 의 국…
Korean 16.2 KB
2025-03-25 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 22.4 KB
2025-03-14 00:00
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
Korean 523.9 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 171.6 KB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 11.3 KB
2025-03-10 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 153.4 KB

Automate Your Workflow. Get a real-time feed of all FutureChem Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for FutureChem Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.